I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Infigratinib in Recurrent Glioblastoma Patients
In the lead-in cohort, a total of 20 participants will be enrolled into the proposed phase 0 clinical trial. Participants will be administered infigratinib prior to surgical resection of their tumor.
FGFR1
glioblastoma multiforme
measurable disease
serum pregnancy test
temozolomide
- 0 views
- 05 Aug, 2020